Nutrition Business Journal
Nutrition Capital Network news: Innophos Buys Triarco in $46 Million Deal

Nutrition Capital Network news: Innophos Buys Triarco in $46 Million Deal

Innophos Holdings Inc. (Cranbury, N.J.), a global producer of specialty grade phosphate products for the food, pharmaceutical and industrial markets, has acquired Triarco Industries Inc. (Wayne, N.J.), a manufacturer of custom ingredients for the food, beverage, dietary supplement and nutraceutical industries. An Innophos subsidiary purchased all of Triarco's assets for $45 million in cash plus $1 million in shares of Innophos Holdings’ common stock. In business for more than 30 years, privately held Triarco has annualized revenues of approximately $25 million and specializes in botanical and enzyme-based ingredients, according to Innophos, which described the acquisition as “highly complementary” to its mineral ingredients businesses Kelatron and AMT acquired in 2011 and 2012. “The combined businesses of Kelatron, AMT and Triarco enhance Innophos' position in the attractive high growth nutritional ingredients end markets with annual revenues in excess of $50 million,” the company said. Innophos’s annual revenues in fiscal year 2011 were $810 million. Formerly part of Rhodia, it was taken private by Bain Capital in 2004 and completed an IPO in 2006.

Disclaimer: NCN does not warrant the accuracy, reliability, or timeliness of any NCN news item. Before relying on any NCN News item the information should be independently verified.

For more finance and investment information, visit Nutrition Capital Network news

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.